A New England Journal of Medicine study published in 2021 found participants receiving GLP-1 drugs were more likely to show significant, sustained weight loss compared with those getting a placebo
Primary Purpose and Dosing Retatrutide is being developed to specifically treat weight loss, but this is not true for all other GLP-1 medications
The clinically important interactions are with insulin and sulfonylureas (high hypoglycemia risk), warfarin (INR monitoring needed), oral contraceptives (slight absorption change), levothyroxine (timing matters), and antibiotics that require precise blood levels
Klinic's Metabolic Health Program in Tucson Our three-step program is designed to ease the process of starting tirzepatide treatment: Step 1: Connect With a Licensed Provider Begin with a short form to verify your insurance coverage
These effects were observed as early as month one and persisted throughout the study
Our team at Centra Internal Medicine will guide you through every step of semaglutide therapy